Last updated: 3 months ago
Ionis Pharmaceuticals FY 2024 Financial Report: Cautious Hold Amid Rising Losses
Explore Ionis Pharmaceuticals' FY 2024 financial analysis, highlighting revenue challenges, partnerships, and a 'Hold' recommendation as operational expenses rise.